| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.53 | 0.002 |